Oklahoma nitrone-007 is an effective anticancer therapeutic agent targeting inflammatory and immune metabolism pathways in endometrial cancer.

J Pharmacol Exp Ther · 2025 · PMC13095626 · PMID 39893009

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

Additionally, we observed a decrease in pSMAD2 and pSMAD3 levels in the OKN-007–treated tumors relative to the other treatment groups; however, it did not reach statistical significance ( Fig. 5 , A and C).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.